PBE vs. PJP ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to PowerShares Dynamic Pharmaceuticals (PJP)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$68.40
Average Daily Volume
6,342
30
PJP
PowerShares Dynamic Pharmaceuticals
PJP Description
The PowerShares Dynamic Pharmaceuticals Portfolio (Fund) is based on the Dynamic Pharmaceutical IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US pharmaceuticals companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.Grade (RS Rating)
Last Trade
$85.66
Average Daily Volume
8,288
25
Performance
| Period | PBE | PJP |
|---|---|---|
| 30 Days | -0.98% | -3.03% |
| 60 Days | -5.20% | -3.63% |
| 90 Days | -4.17% | -2.47% |
| 12 Months | 20.11% | 22.14% |
PBE Overweight 26 Positions Relative to PJP
| Symbol | Grade | Weight | |
|---|---|---|---|
| ILMN | C | 5.64% | |
| ALNY | D | 4.78% | |
| NBIX | C | 4.18% | |
| XNCR | B | 3.88% | |
| EXEL | B | 3.86% | |
| TGTX | B | 3.78% | |
| BMRN | F | 3.76% | |
| MNKD | B | 3.7% | |
| NTRA | A | 3.56% | |
| INCY | C | 3.35% | |
| VCYT | B | 3.28% | |
| ACAD | C | 3.06% | |
| CPRX | C | 3.0% | |
| BPMC | C | 2.91% | |
| TECH | F | 2.89% | |
| VCEL | A | 2.79% | |
| OPK | B | 2.78% | |
| RGEN | D | 2.76% | |
| PTGX | D | 2.75% | |
| QGEN | D | 2.59% | |
| BCRX | D | 2.56% | |
| HALO | F | 2.42% | |
| COLL | F | 2.27% | |
| CDNA | D | 1.92% | |
| NVAX | F | 1.83% | |
| MYGN | F | 1.61% |
PBE Underweight 21 Positions Relative to PJP
| Symbol | Grade | Weight | |
|---|---|---|---|
| ABT | B | -5.77% | |
| JNJ | D | -5.29% | |
| CORT | B | -5.29% | |
| PFE | F | -5.12% | |
| ABBV | F | -4.91% | |
| MRK | F | -4.79% | |
| LLY | F | -4.67% | |
| BMY | B | -4.07% | |
| GILD | B | -4.0% | |
| PBH | A | -3.82% | |
| PCRX | C | -3.78% | |
| LGND | C | -3.63% | |
| JAZZ | B | -3.62% | |
| VTRS | A | -3.61% | |
| AMRX | C | -3.55% | |
| SUPN | B | -3.47% | |
| INVA | D | -3.37% | |
| ANIP | D | -3.12% | |
| AMPH | F | -3.11% | |
| PRGO | C | -3.08% | |
| GERN | C | -2.66% |
PBE: Top Represented Industries & Keywords
PJP: Top Represented Industries & Keywords
Compare ETFs
